Which hedge funds own DGX? QUEST DIAGNOSTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
11 of the hedge funds tracked by WhaleCreep disclosed a position in DGX (QUEST DIAGNOSTICS INC) in their Q2 2026 13F filings, worth $212.1m in total. The largest holder by portfolio weight is Casdin Capital at 0.5% of its book. 1 manager opened a new position this quarter: Point72 Asset Management LP. 1 exited: Maverick Capital.
11tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold DGX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Casdin Capital | Q2 2026 | 0.5% | $10.6m | 50,000 | 0% | held |
| Woodline Partners | Q2 2026 | 0.3% | $103.0m | 485,841 | -18% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $57.2m | 269,760 | 35% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $3.3m | 15,507 | 759% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $28.2m | 133,211 | -62% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $5.0m | 23,380 | – | new |
| Horizon Kinetics | Q2 2026 | 0.0% | $614.7k | 2,900 | 0% | held |
| Bridgewater Associates | Q2 2026 | 0.0% | $796.1k | 3,756 | 8% | added |
| Millennium Management | Q2 2026 | 0.0% | $2.4m | 11,434 | -77% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $1.0m | 4,814 | -97% | reduced |
| Ancora Advisors | Q2 2026 | 0.0% | $29.0k | 137 | -64% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Maverick Capital | 0.0% | $540.1k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Caxton Associates | Q4 2024 | 0.0% |
How has hedge fund ownership of DGX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 11 | $212.1m |
| Q1 2026 | 12 | $278.0m |
| Q4 2025 | 8 | $91.2m |
| Q3 2025 | 5 | $27.5m |
| Q2 2025 | 4 | $28.3m |
| Q1 2025 | 5 | $70.9m |
| Q4 2024 | 8 | $82.6m |
| Q3 2024 | 8 | $96.1m |
| Q2 2024 | 8 | $182.3m |
| Q1 2024 | 7 | $83.4m |
| Q4 2023 | 7 | $123.9m |
| Q3 2023 | 7 | $101.0m |
| Q2 2023 | 7 | $247.5m |
| Q1 2023 | 8 | $158.9m |
| Q4 2022 | 8 | $306.2m |
| Q3 2022 | 9 | $141.5m |
Counts every tracked manager that disclosed DGX in that quarter's filing, including managers that have since stopped filing.